http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1170378-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2000-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1170378-A1 |
| titleOfInvention | Method for monitoring the effect of cancer therapies |
| abstract | A method for monitoring the effect of cancer therapies with growth factorninhibitors and intracellular signal transduction modulators (,,growth factor cancerndrugs"), which act by interfering with overexpression of normal or mutated formsnof growth factor receptors, the overproduction of growth factors or defects in thensignalling cascade downstream the activated growth factor receptors. The methodnis based on measuring telomerase activity in a sample from an individual diagnosednfor cancer and treated with the growth factor cancer drug and correlating anreduction of telomerase activity with a favourable therapeutic intervention with thendrug. |
| priorityDate | 2000-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 169.